Cerity Partners’s Qiagen QGEN Stock Holding History

Cerity Partners’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$884K	Buy	22,601 +14,384	+175%	+$534K	﹤0.01%	2073
2026 Q1	$329K	Buy	8,217 +1,426	+21%	+$67.5K	﹤0.01%	2550
2025 Q4	$305K	Sell	6,791 -5,155	-43%	-$238K	﹤0.01%	2404
2025 Q3	$534K	Sell	11,946 -2,774	-19%	-$133K	﹤0.01%	1931
2025 Q2	$707K	Buy	+14,720	New	+$640K	﹤0.01%	1692
2025 Q1	–	Sell	-17,639	Closed	-$814K	–	2598
2024 Q4	$814K	Buy	17,639 +3,645	+26%	+$163K	﹤0.01%	1514
2024 Q3	$656K	Buy	13,994 +5,009	+56%	+$228K	﹤0.01%	1625
2024 Q2	$380K	Buy	+8,985	New	+$394K	﹤0.01%	1683
2024 Q1	–	Sell	-4,781	Closed	-$220K	–	2340
2023 Q4	$220K	Buy	+4,781	New	+$203K	﹤0.01%	1674
2023 Q2	–	Sell	-5,345	Closed	-$2.25M	–	1891
2023 Q1	$2.25M	Buy	5,345 +677	+15%	+$34.4K	0.01%	684
2022 Q4	$247K	Buy	+4,668	New	+$230K	﹤0.01%	1233
2022 Q1	–	Sell	-3,894	Closed	-$233K	–	1073
2021 Q4	$233K	Buy	+3,894	New	+$223K	﹤0.01%	878
2019 Q2	–	Sell	-19,431	Closed	-$838K	–	568
2019 Q1	$838K	Buy	19,431 +9,648	+99%	+$388K	0.06%	262
2018 Q4	$357K	Buy	9,783 +827	+9%	+$30.7K	0.02%	375
2018 Q3	$360K	Buy	+8,956	New	+$358K	0.02%	386

Other funds holding QGEN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Cerity Partners's QGEN Position: Q2 2026 in Review

Cerity Partners increased its Qiagen (QGEN) stake by 175% in Q2 2026, buying an estimated $534K and bringing the position to 22,601 shares worth $884K. The position accounts for ﹤0.01% of the portfolio, ranked #2073.

Cerity Partners first reported a position in QGEN in Q3 2018 and has held it in 15 quarters since. The position peaked at $2.25M in Q1 2023. 311 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

Cerity Partners held 22,601 shares of Qiagen worth $884K as of Q2 2026.
Cerity Partners bought 14,384 Qiagen shares in Q2 2026, an estimated $534K.
Qiagen made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2073 holding.
Cerity Partners first reported a position in Qiagen in Q3 2018 and has held it in 15 quarters since.
Cerity Partners's Qiagen position peaked at $2.25M in Q1 2023.
311 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.